|
| Exchange Disseminated Time 29/10/2015 16:22:50 | Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2015:
The Unaudited Standalone results for the Quarter ended September 30, 2015
"The Company has posted a net profit of Rs. 3667.14 million for the quarter ended September 30, 2015 where as the same was at Rs. 1164.27 million for the quarter ended September 30, 2014. Total Income is Rs. 15929.05 million for the quarter ended September 30, 2015 where as the same was at Rs. 7117.53 million for the quarter ended September 30, 2014.
Consequent to giving effect to the Scheme during the quarter ended March 31, 2015, the standalone figures for the current quarter are not comparable with that of the corresponding quarter ended September 30, 2014."
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended September 30, 2015
The Group has posted a net profit after taxes, minority interest and share of profit of associates of Rs. 2004.05 million for the quarter ended September 30, 2015. Total Income is Rs. 18754 .37 million for the quarter ended September 30, 2015. |
|
|